{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:18:45Z","timestamp":1793215125038,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Healthy Longevity"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.lanhl.2026.100827","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:23:37Z","timestamp":1780428217000},"page":"100827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2106-6175","authenticated-orcid":false,"given":"Nikhil","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina R","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick D","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-7586","authenticated-orcid":false,"given":"Stuart H","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Duckworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanhl.2026.100827_bib1","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.lanhl.2026.100827_bib2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.bot.0000155311.04886.7e","article-title":"Mortality after low-energy fractures in patients aged at least 45 years old","volume":"19","author":"Shortt","year":"2005","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.lanhl.2026.100827_bib3","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00198-016-3542-6","article-title":"Second fractures among older adults in the year following hip, shoulder, or wrist fracture","volume":"27","author":"Bynum","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.lanhl.2026.100827_bib4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.lanhl.2026.100827_bib5","series-title":"Osteoporotic fracture and systemic skeletal disorders","first-page":"339","article-title":"Teriparatide","author":"Marin","year":"2024"},{"key":"10.1016\/j.lanhl.2026.100827_bib6","first-page":"499","article-title":"Teriparatide in the management of osteoporosis","volume":"2","author":"Bodenner","year":"2007","journal-title":"Clin Interv Aging"},{"issue":"suppl 1","key":"10.1016\/j.lanhl.2026.100827_bib7","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0020-1383(16)30009-2","article-title":"Use of teriparatide in osteoporotic fracture patients","volume":"47","author":"Collinge","year":"2016","journal-title":"Injury"},{"key":"10.1016\/j.lanhl.2026.100827_bib8","series-title":"Abaloparatide","author":"Akel","year":"2025"},{"key":"10.1016\/j.lanhl.2026.100827_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.lanhl.2026.100827_bib10","series-title":"Romosozumab","author":"Krupa","year":"2025"},{"key":"10.1016\/j.lanhl.2026.100827_bib12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00198-021-05847-0","article-title":"Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis","volume":"32","author":"Eastman","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.lanhl.2026.100827_bib13","series-title":"Cochrane handbook for systematic reviews of interventions","first-page":"95","article-title":"Searching for studies","author":"Lefebvre","year":"2008"},{"key":"10.1016\/j.lanhl.2026.100827_bib14","article-title":"Zoledronic acid does not retard bone union: a randomized controlled trial in fragility intertrochanteric femur fractures","volume":"15","author":"Gulia","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.lanhl.2026.100827_bib15","first-page":"234","article-title":"Role of supplemental teriparatide therapy in management of osteoporotic intertrochanteric femur fractures","volume":"11","author":"Rana","year":"2021","journal-title":"Int J Burns Trauma"},{"key":"10.1016\/j.lanhl.2026.100827_bib16","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00198-010-1473-1","article-title":"Association between timing of zoledronic acid infusion and hip fracture healing","volume":"22","author":"Col\u00f3n-Emeric","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.lanhl.2026.100827_bib17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/jbmr.3679","article-title":"Effect of alendronic acid on fracture healing: a multicenter randomized placebo-controlled trial","volume":"34","author":"Duckworth","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.lanhl.2026.100827_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jos.2024.03.005","article-title":"Does early administration of denosumab delay bone healing after intertrochanteric femoral fractures?","volume":"30","author":"Hino","year":"2025","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.lanhl.2026.100827_bib19","article-title":"Intravenous bisphosphonate therapy does not delay fracture healing in inter-trochanteric femur fractures\u2014a randomised controlled study","volume":"20","author":"Jalan","year":"2021","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.lanhl.2026.100827_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cjtee.2016.07.001","article-title":"Treatment of osteoporotic intertrochanteric fractures by zoledronic acid injection combined with proximal femoral nail anti-rotation","volume":"19","author":"Li","year":"2016","journal-title":"Chin J Traumatol"},{"key":"10.1016\/j.lanhl.2026.100827_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/os.12460","article-title":"Study on zoledronic acid reducing acute bone loss and fracture rates in elderly postoperative patients with intertrochanteric fractures","volume":"11","author":"Liu","year":"2019","journal-title":"Orthop Surg"},{"key":"10.1016\/j.lanhl.2026.100827_bib22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1302\/0301-620X.94B7.29079","article-title":"Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?","volume":"94","author":"Kim","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.lanhl.2026.100827_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.rbo.2014.06.012","article-title":"Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study","volume":"50","author":"Oliveira","year":"2015","journal-title":"Rev Bras Ortop"},{"key":"10.1016\/j.lanhl.2026.100827_bib24","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1302\/0301-620X.95B11.31652","article-title":"Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time","volume":"95-B","author":"Uchiyama","year":"2013","journal-title":"Bone Joint J"},{"key":"10.1016\/j.lanhl.2026.100827_bib25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2106\/JBJS.K.01434","article-title":"Early initiation of bisphosphonate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures","volume":"94","author":"Gong","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.lanhl.2026.100827_bib26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2106\/JBJS.F.00484","article-title":"Alendronate improves screw fixation in osteoporotic bone","volume":"89","author":"Moroni","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.lanhl.2026.100827_bib27","article-title":"The efficacy of osteoporotic treatment in patients with new spinal vertebral compression fracture pain, ADL, QOL, bone metabolism and fracture-healing\u2014in comparison with weekly teriparatide with bisphosphonate","volume":"11","author":"Shigenobu","year":"2019","journal-title":"Bone Rep"},{"key":"10.1016\/j.lanhl.2026.100827_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3067","article-title":"Effect of teriparatide or risedronate in elderly patients with a recent pertrochanteric hip fracture: final results of a 78-week randomized clinical Trial","volume":"32","author":"Malouf-Sierra","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.lanhl.2026.100827_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00198-021-06065-4","article-title":"Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial","volume":"33","author":"Nieves","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.lanhl.2026.100827_bib30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/sctm.20-0308","article-title":"Safety and efficacy of Wharton\u2019s jelly-derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: a phase I\/IIa study","volume":"10","author":"Shim","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.lanhl.2026.100827_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/17453674.2015.1073050","article-title":"PTH 1-34 (teriparatide) may not improve healing in proximal humerus fractures. A randomized, controlled study of 40 patients","volume":"87","author":"Johansson","year":"2016","journal-title":"Acta Orthop"},{"key":"10.1016\/j.lanhl.2026.100827_bib32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1359\/jbmr.090731","article-title":"Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures","volume":"25","author":"Aspenberg","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.lanhl.2026.100827_bib33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4055\/cios22280","article-title":"Effectiveness of weekly teriparatide injection in postmenopausal patients with hip fractures","volume":"15","author":"Lee","year":"2023","journal-title":"Clin Orthop Surg"},{"key":"10.1016\/j.lanhl.2026.100827_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00774-019-01023-x","article-title":"Comparison of once-weekly teriparatide and alendronate against new osteoporotic vertebral fractures at week 12","volume":"38","author":"Ikeda","year":"2020","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.lanhl.2026.100827_bib35","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2106\/JBJS.J.01379","article-title":"Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women","volume":"93","author":"Peichl","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.lanhl.2026.100827_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03720-2","article-title":"A randomized controlled trial of teriparatide for accelerating bone union and improving clinical outcomes in patients with pertrochanteric fracture fixation","volume":"15","author":"Tanavalee","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.lanhl.2026.100827_bib37","first-page":"615","article-title":"Assessing efficacy of teriparatide in promoting lower limb fracture healing: a prospective interventional study","volume":"10","author":"Nag","year":"2021","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"key":"10.1016\/j.lanhl.2026.100827_bib38","first-page":"288","article-title":"Assessment of the effect of teriparatide on lower limb fracture healing: an interventional study","volume":"10","author":"Kumar Singh","year":"2021","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"key":"10.1016\/j.lanhl.2026.100827_bib39","first-page":"57","article-title":"Effect of teriperatide in healing of intertrochanteric fractures in elderly persons","volume":"14","author":"Aggarwal","year":"2025","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"key":"10.1016\/j.lanhl.2026.100827_bib40","article-title":"Role of supplemental teriparatide therapy to augment functional and radiological outcomes in osteoporotic intertrochanteric hip fractures in the elderly population","volume":"14","author":"Mishra","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.lanhl.2026.100827_bib41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2106\/JBJS.19.00790","article-title":"A randomized, placebo-controlled study of romosozumab for the treatment of hip fractures","volume":"102","author":"Schemitsch","year":"2020","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.lanhl.2026.100827_bib42","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.lanhl.2026.100827_bib43","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2146\/ajhp090506","article-title":"Risks and benefits of long-term bisphosphonate therapy","volume":"67","author":"Schmidt","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.lanhl.2026.100827_bib44","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lanhl.2026.100827_bib45","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00590-021-03134-6","article-title":"Radiographic union score for tibia (RUST) scoring system in adult diaphyseal femoral fractures treated with intramedullary nailing: an assessment of interobserver and intraobserver reliability","volume":"32","author":"Panchoo","year":"2022","journal-title":"Eur J Orthop Surg Traumatol"}],"container-title":["The Lancet Healthy Longevity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666756826000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666756826000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:58:45Z","timestamp":1785909525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666756826000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666756826000115"],"URL":"https:\/\/doi.org\/10.1016\/j.lanhl.2026.100827","relation":{},"ISSN":["2666-7568"],"issn-type":[{"value":"2666-7568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Healthy Longevity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanhl.2026.100827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanhl.2026.100834","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100827"}}